Long-acting narcotic antagonist complexes.
We evaluated the ability of close to 100 organic acids to form water-soluble salts with methadone, cyclazocine, naloxone, naltrexone and, more recently, diprenorphine. About half the acids yielded insoluble salts. Polybasic acids affording insoluble salts were evaluated for their ability to form drug:acid:metal complexes with the polyvalent metal ions, Zn++, Al+++, Mg++ and Ca++. Optimum conditions for forming complexes have been developed and the consistency of their composition has been established. Salts were analyzed spectrophotometrically for drug content, and complexes were analyzed for drug and metal content. The in vitro degree of dissociation at equilibrium was measured for the preparations suspended in a simulated physiological buffer, pH 7.3. Preparations of the narcotic antagonist drugs showing relatively low degrees of dissociation in vitro, since it early appeared that a high degree of dissociation contraindicated a prolonged duration of pharmacological action, were evaluated in mice after intramuscular administration at several dose levels by the mouse tail-flick test for the potency and duration of their morphine antagonist activity. Our most promising preparations to date, showing the most prolonged durations of action without evidence of gross toxicity, are naltrexone zinc tannate and naltrexone aluminum tannate. These are undergoing detailed evaluation as potential clinical candidates. Thus far, the most useful of several dosage forms studied is s suspension in an aluminum monostearate gel.
D000535:Aluminum / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000378:metabolism; D002021:Buffers; D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations; D004174:Diprenorphine / Q000008:administration & dosage / Q000494:pharmacology; D004355:Drug Stability; D008691:Methadone / Q000008:administration & dosage / Q000494:pharmacology; D051379:Mice; D009020:Morphine / Q000037:antagonists & inhibitors; D009271:Naltrexone / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000008:administration & dosage*; D011930:Reaction Time / Q000187:drug effects; D015032:Zinc / Q000494:pharmacology
D002021:Buffers; D003692:Delayed-Action Preparations; D009292:Narcotic Antagonists; D004174:Diprenorphine; D009271:Naltrexone; D009020:Morphine; D000535:Aluminum; D015032:Zinc; D008691:Methadone